Constrained peptides mimic a viral suppressor of RNA silencing. Issue 22 (6th December 2021)

• Record Type: Journal Article
• Authors: Kuepper, Arne; McLoughlin, Niall M; Neubacher, Saskia; Yeste-Vázquez, Alejandro; Collado Camps, Estel; Nithin, Chandran; Mukherjee, Sunandan; Bethge, Lucas; Bujnicki, Janusz M; Brock, Roland; Heinrichs, Stefan; Grossmann, Tom N
• Is Part Of: Nucleic acids research. Volume 49:Issue 22(2021)
• Page Start: 12622
• Page End: 12633
• Publication Date: 2021-12-06
• Subjects: Nucleic acids -- Periodicals; Molecular biology -- Periodicals; 572.805
• DOI: 10.1093/nar/gkab1149
• Languages: English
• ISSNs: 0305-1048

Abstract

Abstract: The design of high-affinity, RNA-binding ligands has proven very challenging. This is due to the unique structural properties of RNA, often characterized by polar surfaces and high flexibility. In addition, the frequent lack of well-defined binding pockets complicates the development of small molecule binders. This has triggered the search for alternative scaffolds of intermediate size. Among these, peptide-derived molecules represent appealing entities as they can mimic structural features also present in RNA-binding proteins. However, the application of peptidic RNA-targeting ligands is hampered by a lack of design principles and their inherently low bio-stability. Here, the structure-based design of constrained α-helical peptides derived from the viral suppressor of RNA silencing, TAV2b, is described. We observe that the introduction of two inter-side chain crosslinks provides peptides with increased α-helicity and protease stability. One of these modified peptides (B3) shows high affinity for double-stranded RNA structures including a palindromic siRNA as well as microRNA-21 and its precursor pre-miR-21. Notably, B3 binding to pre-miR-21 inhibits Dicer processing in a biochemical assay. As a further characteristic this peptide also exhibits cellular entry. Our findings show that constrained peptides can efficiently mimic RNA-binding proteins rendering them potentially useful for the design of bioactive RNA-targeting ligands.